Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? - Wikidata - wikimedia - TriplyDB

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

http://www.wikidata.org/entity/Q38322257

about

Adjuvant chemotherapy for rectal cancer: Is it needed?mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma.Pre- and post-surgery treatments in rectal cancer: a long-term single-centre experience.On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.Recent advances in multidisciplinary approach for rectal cancer.Current topics in the multimodality treatment of locally advanced rectal cancer.Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry.Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes.What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

P2860

Q26775099-558363FE-3177-4A8C-8BB3-63206A3C62CC Q36938341-DB167872-7368-4A7E-8D1E-B6BFC09DBE59 Q37672022-933DB1F8-275D-4468-A4CF-7E3076551837 Q37715201-6FF490A5-CEB1-4176-9BD1-9EC13A939626 Q38534726-A401EB5F-44FC-4BE4-B95C-8BCBB8F862A5 Q38734893-212C3DD4-1D47-4446-9804-DC961D6F6B06 Q39299445-B1291DAF-DD26-43FA-9D50-6D33CB2983FF Q50091631-C93E9A17-9004-4727-B8AD-9D60F41BE9BE Q51049865-5C08B8DF-858D-4144-815C-131AC1251495 Q51630354-E27A548E-6AA8-4B62-B2D0-9F8C456BEC3D Q53579641-2D084C44-623C-4FC6-AC0A-A04797A2B014

P2860

Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?

http://www.wikidata.org/entity/Q38322257

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Review on adjuvant chemotherap ...... ent guidelines differ so much?

@en

type

label

Review on adjuvant chemotherap ...... ent guidelines differ so much?

@en

prefLabel

Review on adjuvant chemotherap ...... ent guidelines differ so much?

@en

P1433

Q38322257-7908E89D-1A7A-4D92-9376-9A9D8D723460

P1476

Q38322257-F8E2E55C-CA5A-4BBF-9408-2D0F886AC6C6

P2093

Q38322257-3BD15807-799D-4C70-BB41-51B5DF96ECE7

Q38322257-5EC0110A-3947-4864-B997-162D7B74DF1A

Q38322257-FB7773A9-669C-4238-886B-FCD519633139

P2860

Q38322257-0067C356-D144-448B-8E75-4B76F3A8322D

Q38322257-0198F999-0C4E-494C-92D9-F7808AA12303

Q38322257-064FE4E9-4C5D-473B-81FF-24592E54B017

Q38322257-08009465-B23F-4288-B435-2A3E5C97D671

Q38322257-0A77B74C-6F1F-42BA-B01A-3561E76DA21C

Q38322257-0AF64269-F09C-4B45-8706-20731C4BF0A5

Q38322257-0F63169F-A4C9-4BCD-A104-3E6238FC7E16

Q38322257-12A33B0B-623E-4C66-90E7-FDB22472EC64

Q38322257-14A1E668-C825-4F4E-824F-DC2902A2D272

Q38322257-213D40FB-F6BF-4820-9663-30C1D00AD215

P304

Q38322257-197601AB-EA4F-4E60-9577-DF2C23BEE933

P31

Q38322257-81C04847-0A14-4BA4-AED8-1FA4CD9737A3

P356

Q38322257-9726B2FE-DDC7-4EA9-BBE1-D6BC8089F3DA

P433

Q38322257-1C5CB510-E54C-43DB-85BD-B86A88A589CE

P478

Q38322257-C11CB11C-F92C-47D7-BCCE-5C6AAF1AD4C8

P50

Q38322257-245B14A7-BF78-4FE6-AA88-BAD936988D78

Q38322257-563ACA22-8086-4CD4-83D6-726E1ABB8E7E

Q38322257-7B589904-61CA-4C35-AA8F-1E34AED36257

P577

Q38322257-C4BF4029-D102-4572-901A-E3E76E84FF30

P698

Q38322257-A395EA8A-D5EB-4CCD-BFB1-188E50A854EE

P921

Q38322257-6B4DFB73-70EB-447B-8D24-60717B4FD2C0

P356

0284186X.2014.993768

P1433

Acta Oncologica

P1476

Review on adjuvant chemotherap ...... ent guidelines differ so much?

@en

P2093

Halfdan Sorbye

http://www.w3.org/2001/XMLSchema#string

Laurids Ø Poulsen

http://www.w3.org/2001/XMLSchema#string

Mette Yilmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular characterization of human colon and rectal cancer

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007

Effective surgical adjuvant therapy for high-risk rectal carcinoma.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Estimates of the cancer incidence and mortality in Europe in 2006.

P304

437-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0284186X.2014.993768

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Camilla Qvortrup

P577

2015-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25597332

http://www.w3.org/2001/XMLSchema#string

P921